Ortiz, Luis E.
Morse, Anne Marie
Krahn, Lois
Lavender, Maggie
Horsnell, Matthew
Cronin, Dianna
Schneider, Beth
Gudeman, Jennifer https://orcid.org/0000-0002-7375-5020
Funding for this research was provided by:
Avadel Pharmaceuticals
Article History
Accepted: 26 November 2024
First Online: 20 March 2025
Declarations
:
: This article has been published as part of a journal supplement wholly funded by Avadel Pharmaceuticals (Chesterfield, MO, USA). This study was funded by Avadel Pharmaceuticals. Avadel Pharmaceuticals was involved in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. Open access publication and publication costs were funded by Avadel Pharmaceuticals.
: L.E.O. is a consultant to Harmony Biosciences and has served on advisory boards for Avadel Pharmaceuticals and Jazz Pharmaceuticals. A.M.M. has served as a consultant, speaker, and/or on advisory boards for Avadel Pharmaceuticals, Eisai, Harmony Biosciences, Jazz Pharmaceuticals, Alkermes, and Takeda Pharmaceutical Co; has received grant funding from National Institutes of Health, UCB Pharmaceuticals, Jazz Pharmaceuticals, ResMed Foundation, Coverys Foundation, Harmony Biosciences, and Geisinger Health Plan; is the CEO of DAMM Good Sleep, LLC; and serves as an advisor for Neura Health and Floraworks. L.K. is a consultant for and/or has served on advisory boards for Avadel Pharmaceuticals and Takeda and has received research funding from Takeda and Axsome Therapeutics. M.L. is a speaker or has received consulting fees for participation on advisory boards for Avadel Pharmaceuticals, Harmony Biosciences, and Jazz Pharmaceuticals. M.H. is a consultant to Avadel; has received compensation or honoraria from Alkermes, Axsome Therapeutics, Centessa Pharmaceuticals, and Harmony Biosciences; and is a member of the Sleep Consortium Advisory Board. D.C. and B.S. are employees of MyHealthTeam, which received funding to conduct the research. J.G. is an employee of Avadel Pharmaceuticals.
: This study qualified for institutional review board exemption through Advarra per the US Department of Health and Human Services regulations found at 45 CFR 46.104(d)(2).
: Written informed consent was obtained from each respondent prior to beginning the survey.
: Not applicable.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: L.E.O.: writing—review and editing, formal analysis. A.M.M.: writing—review and editing, formal analysis. L.K.: writing—review and editing, formal analysis. M.L.: writing—review and editing, formal analysis. M.H.: writing—review and editing, formal analysis. D.C.: data curation, writing—review and editing, formal analysis. B.S: data curation, writing—review and editing, formal analysis. J.G.: writing—review and editing, formal analysis. All authors have read and approved the final submitted manuscript and have agreed to be accountable for the work.